Press Releases

Titan Medical Reports Second Quarter 2020 Financial Results

TORONTO (August 12, 2020) – Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces financial results for the three and six months ended June 30, 2020. All financial results are prepared in accordance with International Accounting Standards (“IAS”) 34 on a […]

Titan Medical Confirms Receipt of Deficiency Notice from Nasdaq

TORONTO (August 10, 2020) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that on August 5, 2020, the Company received a deficiency notice from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department that it was not […]

Titan Medical Reports Design Enhancements to Single-Port Robotic Surgical Instruments on Product Development Resumption

TORONTO (July 30, 2020) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has completed design enhancements to instruments compatible for use with its single-port robotic surgical system. As previously disclosed, the Company resumed […]

Titan Medical to Present at the Society of Robotic Surgery 2020 World Robotic Symposium

TORONTO (July 27, 2020) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that David McNally, President and CEO of Titan Medical, will present in the plenary session titled “Future Robotic Platforms” on Saturday, August 1 […]

Titan Medical Issues Shareholder Update Letter

TORONTO (July 14, 2020) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today issued an update letter to its shareholders. The letter, authored by David McNally, President & CEO, Chairman, may be found on the Company’s […]

error: Content is protected !!